Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT-Reference-Cited by-同舟云学术

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Published:2013-03-28 Issue:13 Volume:121 Page:2529-2532
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Jantunen Esa¹,Boumendil Ariane²,Finel Herve²,Luan Jian-Jian²,Johnson Peter³,Rambaldi Alessandro⁴,Haynes Andrew⁵,Duchosal Michel A.⁶,Bethge Wolfgang⁷,Biron Pierre⁸,Carlson Kristina⁹,Craddock Charles¹⁰,Rudin Claudius¹¹,Finke Jurgen¹²,Salles Gilles¹³,Kroschinsky Frank¹⁴,Sureda Anna¹⁵,Dreger Peter¹⁶

Affiliation:

1. University of Eastern Finland/Clinical Medicine and Department of Medicine, Kuopio University Hospital, Kuopio, Finland;

2. EBMT Lymphoma Working Party, Paris, France;

3. Department of Haematology, Western General Hospital, Edinburgh, United Kingdom;

4. Hematology and BMT Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;

5. Nottingham City Hospital, Nottingham, United Kingdom;

6. Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland;

7. Medizinische Klinik II, Universitaet Tuebingen, Tuebingen, Germany;

8. Centre Leon Bernard, Lyon, France;

9. Department of Medicine, University Hospital, Uppsala, Sweden;

10. Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom;

11. Department of Clinical Haematology, Royal Devon and Exeter Hospital, Exeter, United Kingdom;

12. Department of Medicine, University of Freiburg, Freiburg, Germany;

13. Hospices Civils de Lyon and Universite Claude Bernard Lyon-1, Hematologie, Pierre Benite, France;

14. Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany;

15. Haematology Department, Addenbrookes Hospital, Cambridge, United Kingdom; and

16. Medizinische Klinik V, Universität Heidelberg, Heidelberg, Germany

Abstract

Key Points ASCT provides long-term remission in the majority of EATL patients transplanted in first complete or partial remission. ASCT should be considered in transplant-eligible EATL patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/13/2529/1365053/2529.pdf

Reference14 articles.

1. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.;Delabie;Blood,2011

2. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.;Gale;J Clin Oncol,2000

3. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma.;Daum;J Clin Oncol,2003

4. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.;Al-Toma;Gut,2007

5. How I treat enteropathy-associated T-cell lymphoma.;Di Sabatino;Blood,2012

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China;American Journal of Clinical Pathology;2024-08-09

2. How I treat peripheral T-cell lymphomas;Russian journal of hematology and transfusiology;2024-03-19

3. Monomorphic epitheliotropic intestinal T-cell lymphoma with bone marrow involved: A case report;World Journal of Clinical Cases;2024-02-06

4. Primary Intestinal T-cell Lymphomas – A Case Series from a Tertiary Center in South India;Oncology Journal of India;2024-01

5. Refractory celiac disease and lymphomagenesis;Pediatric and Adult Celiac Disease;2024